IL6 and obesity due to melanocortin 4 receptor deficiency: IL-6 levels are elevated in the adipose tissues of patients with diabetes mellitus or obesity, particularly in those with MS symptoms, suggesting that IL-6 could be used as a prognostic indicator for MS and cardiovascular dysfunction.